# Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting

> **NCT00250744** · PHASE2 · COMPLETED · sponsor: **New Mexico Cancer Research Alliance** · enrollment: 200 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Aprepitant vs. Gabapentin
- **DRUG:** Aprepitant vs. Gabapentin

## Key facts

- **NCT ID:** NCT00250744
- **Lead sponsor:** New Mexico Cancer Research Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2011-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00250744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00250744, "Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00250744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*